Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT
Efficacy and Safety of Intracameral Versus Intravitreal Bevacizumab Injection as an Adjunctive Therapy Before Trabeculectomy With Mitomycin-C in Neovascular Glaucoma: A Prospective Randomized Trial
Sponsor: Prince of Songkla University
A NA clinical study on Glaucoma, Neovascular and Vascular Endothelial Growth Factor Overexpression, this trial is actively recruiting participants. The trial is conducted by Prince of Songkla University and has accumulated 9 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Recruiting NA
Status: Unknown → Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Mar 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Mar 2022 — Mar 2024 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jan 2021 — Mar 2022 [monthly]
Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Recruiting NA
-
Sep 2019 — May 2020 [monthly]
Recruiting NA
-
Sep 2018 — Sep 2019 [monthly]
Recruiting NA
First recorded
Aug 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Prince of Songkla University
For direct contact, visit the study record on ClinicalTrials.gov .